Medical Breakthrough Tested in Phase 2 and 3 Trials from Society of Urologic Oncology Clinical Trials Consortium

Schaumburg, IL — As patients, caregivers, and medical professionals focus on Bladder Cancer Awareness Month, many are encouraged that a treatment discovered during Society of Urologic Oncology Clinical Trials Consortium (SUO-CTC) Phase 2 and 3 trials may soon be available. The breakthrough treatment is offering new options to those who suffer bladder cancer that has recurred after initial therapy.

Read Full Press Release